← FDA Drug Approvals (Drugs@FDA)

LAMIVUDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2008-01-29

Drug application

FDA Application #

ANDA078850

Application type

Abbreviated New Drug Application (Generic)

Brand name

LAMIVUDINE

Generic name

Lamivudine

Active ingredients

LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

INVAGEN PHARMS

First approval

2008-01-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown